1,3-DIAZO-4-OXA-[3.3.1]- bicyclic derivatives, process for their manufacture and their use as a medicament in particular for treating diabetes

The present invention concerns the synthesis of small molecules, obtained by a totally innovative process, characterized by a stimulatory effect on the secretion of GLP-1, a gastrointestinal hormone.

Settore:

Life sciences

Research Institution:

Università di Pisa

Publication number:

WO2018220542A1

Technologies, Systems, Applications:

Medical devices development,
Biomedical

Technological Priority:

Biomedical, pharmaceutical, pharmacological technologies
Pubblicato il: